MetLife Investment Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-18,510
| Closed | -$67.6K | – | 2910 |
|
|
2023
Q2 | $67.6K | Buy |
+18,510
| New | +$67.6K | ﹤0.01% | 2856 |
|
|
2022
Q1 | – | Sell |
-11,813
| Closed | -$134K | – | 2740 |
|
|
2021
Q4 | $134K | Buy |
11,813
+5,466
| +86% | +$61.8K | ﹤0.01% | 2292 |
|
|
2021
Q3 | $92.5K | Sell |
6,347
-6,564
| -51% | -$95.6K | ﹤0.01% | 2472 |
|
|
2021
Q2 | $150K | Hold |
12,911
| – | – | ﹤0.01% | 2322 |
|
|
2021
Q1 | $158K | Buy |
12,911
+88
| +0.7% | +$1.07K | ﹤0.01% | 2170 |
|
|
2020
Q4 | $160K | Hold |
12,823
| – | – | ﹤0.01% | 2100 |
|
|
2020
Q3 | $193K | Hold |
12,823
| – | – | ﹤0.01% | 1884 |
|
|
2020
Q2 | $314K | Buy |
12,823
+2,817
| +28% | +$69K | ﹤0.01% | 1630 |
|
|
2020
Q1 | $142K | Hold |
10,006
| – | – | ﹤0.01% | 1878 |
|
|
2019
Q4 | $159K | Buy |
+10,006
| New | +$159K | ﹤0.01% | 2105 |
|